Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Mepolizumab Cuts Asthma Exacerbations Among High-risk Kids.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Slomski A
- Source:
JAMA [JAMA] 2022 Sep 27; Vol. 328 (12), pp. 1171-1172.
- Publication Type:
Journal Article
- Language:
English
- Additional Information
- Source:
Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE
- Publication Information:
Original Publication: Chicago : American Medical Association, 1960-
- Subject Terms:
- Accession Number:
0 (Anti-Asthmatic Agents)
0 (Antibodies, Monoclonal, Humanized)
90Z2UF0E52 (mepolizumab)
- Publication Date:
Date Created: 20220927 Date Completed: 20220929 Latest Revision: 20221003
- Publication Date:
20231215
- Accession Number:
10.1001/jama.2022.16965
- Accession Number:
36166028
No Comments.